ID

15267

Descripción

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02358044

Link

https://clinicaltrials.gov/show/NCT02358044

Palabras clave

Versiones (1)
  1. 24/5/16 24/5/16 -
Subido en

24 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis C NCT02358044

Inglés

Eligibility Hepatitis C NCT02358044

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
weigh ≥ 40 kg and ≤125 kg
Descripción

Body Weight

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005910
documented chronic hcv gt1, gt4, or gt6 infection
Descripción

Chronic hepatitis C virus genotype 1 Communicable Diseases | Hepatitis C virus genotype 4 chronic Communicable Diseases | Hepatitis C virus genotype 6 chronic Communicable Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3805156
UMLS CUI [1,2]
C0009450
UMLS CUI [2,1]
C3532922
UMLS CUI [2,2]
C0205191
UMLS CUI [2,3]
C0009450
UMLS CUI [3,1]
C3532924
UMLS CUI [3,2]
C0205191
UMLS CUI [3,3]
C0009450
cirrhosis/absence of cirrhosis defined by liver biopsy, fibroscan, or fibrosure®
Descripción

Liver Cirrhosis | Liver Cirrhosis Absent | Biopsy of liver | Fibrosure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0193388
UMLS CUI [4]
C1955263
either treatment naïve or pr null responder, pr partial responder, or pr prior relapser
Descripción

Therapy naive | PEGINTERFERON/RIBAVIRIN Therapy non-responder | PEGINTERFERON/RIBAVIRIN Partial responder to therapy | PEGINTERFERON/RIBAVIRIN Relapse Previous

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C1875630
UMLS CUI [2,2]
C0919875
UMLS CUI [3,1]
C1875630
UMLS CUI [3,2]
C1740822
UMLS CUI [4,1]
C1875630
UMLS CUI [4,2]
C0035020
UMLS CUI [4,3]
C0205156
participant and partner both agree to use at least use at least 2 effective methods of contraception from at least 2 weeks prior to day 1 and continue until up to 6 months after last dose of study drug, or longer if dictated by local regulations
Descripción

Contraceptive methods Willing | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
UMLS CUI [2]
C0013230
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
has evidence of decompensated liver disease
Descripción

Decompensated cirrhosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1619727
is coinfected with hepatitis b virus (e.g. hepatitis b surface antigen positive) or human immunodeficiency virus
Descripción

HBV coinfection | Hepatitis B surface antigen positive | Coinfection HIV

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2242656
UMLS CUI [2]
C0149709
UMLS CUI [3,1]
C0275524
UMLS CUI [3,2]
C0019682
history of malignancy ≤5 years prior to signing informed consent, or is under evaluation for other active or suspected malignancy
Descripción

Malignant Neoplasms | Informed Consent | Evaluation Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0021430
UMLS CUI [3,1]
C0220825
UMLS CUI [3,2]
C0006826
has cirrhosis and liver imaging within 6 months of day 1 showing evidence of hepatocellular carcinoma (hcc) or is under evaluation for hcc
Descripción

Liver carcinoma | Liver Cirrhosis | Imaging of liver | Evaluation Liver carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2]
C0023890
UMLS CUI [3]
C2711860
UMLS CUI [4,1]
C0220825
UMLS CUI [4,2]
C2239176
has any of the following conditions: immunologically-mediated disease, organ transplants other than cornea and hair, poor venous access that precludes routine peripheral blood sampling, history of gastric surgery or malabsorption disorders, or any medical condition requiring, or likely to require, chronic systemic administration of corticosteroids during the course of the trial, history of chronic hepatitis not caused by hcv
Descripción

Immune System Diseases | Organ Transplantation | Cornea | Hair | Poor venous access | Peripheral blood specimen | Operation on stomach | Malabsorption Syndrome | systemic steroids chronic | Hepatitis, Chronic Etiology aspects Hepatitis C virus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021053
UMLS CUI [2]
C0029216
UMLS CUI [3]
C0010031
UMLS CUI [4]
C0018494
UMLS CUI [5]
C0577866
UMLS CUI [6]
C1292451
UMLS CUI [7]
C0192398
UMLS CUI [8]
C0024523
UMLS CUI [9,1]
C2825233
UMLS CUI [9,2]
C0205191
UMLS CUI [10,1]
C0019189
UMLS CUI [10,2]
C0015127
UMLS CUI [10,3]
C0220847
Volver a la parte superior de la página

Similar models

Eligibility Hepatitis C NCT02358044

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Body Weight
Item
weigh ≥ 40 kg and ≤125 kg
boolean
C0005910 (UMLS CUI [1])
Chronic hepatitis C virus genotype 1 Communicable Diseases | Hepatitis C virus genotype 4 chronic Communicable Diseases | Hepatitis C virus genotype 6 chronic Communicable Diseases
Item
documented chronic hcv gt1, gt4, or gt6 infection
boolean
C3805156 (UMLS CUI [1,1])
C0009450 (UMLS CUI [1,2])
C3532922 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C3532924 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
C0009450 (UMLS CUI [3,3])
Liver Cirrhosis | Liver Cirrhosis Absent | Biopsy of liver | Fibrosure
Item
cirrhosis/absence of cirrhosis defined by liver biopsy, fibroscan, or fibrosure®
boolean
C0023890 (UMLS CUI [1])
C0023890 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0193388 (UMLS CUI [3])
C1955263 (UMLS CUI [4])
Therapy naive | PEGINTERFERON/RIBAVIRIN Therapy non-responder | PEGINTERFERON/RIBAVIRIN Partial responder to therapy | PEGINTERFERON/RIBAVIRIN Relapse Previous
Item
either treatment naïve or pr null responder, pr partial responder, or pr prior relapser
boolean
C0919936 (UMLS CUI [1])
C1875630 (UMLS CUI [2,1])
C0919875 (UMLS CUI [2,2])
C1875630 (UMLS CUI [3,1])
C1740822 (UMLS CUI [3,2])
C1875630 (UMLS CUI [4,1])
C0035020 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
Contraceptive methods Willing | Investigational New Drugs
Item
participant and partner both agree to use at least use at least 2 effective methods of contraception from at least 2 weeks prior to day 1 and continue until up to 6 months after last dose of study drug, or longer if dictated by local regulations
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Decompensated cirrhosis
Item
has evidence of decompensated liver disease
boolean
C1619727 (UMLS CUI [1])
HBV coinfection | Hepatitis B surface antigen positive | Coinfection HIV
Item
is coinfected with hepatitis b virus (e.g. hepatitis b surface antigen positive) or human immunodeficiency virus
boolean
C2242656 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C0275524 (UMLS CUI [3,1])
C0019682 (UMLS CUI [3,2])
Malignant Neoplasms | Informed Consent | Evaluation Malignant Neoplasms
Item
history of malignancy ≤5 years prior to signing informed consent, or is under evaluation for other active or suspected malignancy
boolean
C0006826 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0220825 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
Liver carcinoma | Liver Cirrhosis | Imaging of liver | Evaluation Liver carcinoma
Item
has cirrhosis and liver imaging within 6 months of day 1 showing evidence of hepatocellular carcinoma (hcc) or is under evaluation for hcc
boolean
C2239176 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C2711860 (UMLS CUI [3])
C0220825 (UMLS CUI [4,1])
C2239176 (UMLS CUI [4,2])
Immune System Diseases | Organ Transplantation | Cornea | Hair | Poor venous access | Peripheral blood specimen | Operation on stomach | Malabsorption Syndrome | systemic steroids chronic | Hepatitis, Chronic Etiology aspects Hepatitis C virus
Item
has any of the following conditions: immunologically-mediated disease, organ transplants other than cornea and hair, poor venous access that precludes routine peripheral blood sampling, history of gastric surgery or malabsorption disorders, or any medical condition requiring, or likely to require, chronic systemic administration of corticosteroids during the course of the trial, history of chronic hepatitis not caused by hcv
boolean
C0021053 (UMLS CUI [1])
C0029216 (UMLS CUI [2])
C0010031 (UMLS CUI [3])
C0018494 (UMLS CUI [4])
C0577866 (UMLS CUI [5])
C1292451 (UMLS CUI [6])
C0192398 (UMLS CUI [7])
C0024523 (UMLS CUI [8])
C2825233 (UMLS CUI [9,1])
C0205191 (UMLS CUI [9,2])
C0019189 (UMLS CUI [10,1])
C0015127 (UMLS CUI [10,2])
C0220847 (UMLS CUI [10,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial